Considerable distance to reach 90-90-90 targets among female sex workers, men who have sex with men and transgender women in Port Moresby, Papua New Guinea: findings from a cross-sectional respondent-driven sampling survey.
Adolescent
Adult
Anti-Retroviral Agents
/ therapeutic use
Condoms
/ statistics & numerical data
Cross-Sectional Studies
Depression
/ epidemiology
Disclosure
Estrenes
Female
HIV Infections
/ blood
Humans
Male
Papua New Guinea
/ epidemiology
Prevalence
Sex Workers
/ statistics & numerical data
Sexual Behavior
/ statistics & numerical data
Sexual and Gender Minorities
/ statistics & numerical data
Sexually Transmitted Diseases
/ epidemiology
Transgender Persons
/ statistics & numerical data
United Nations
Viral Load
Young Adult
Female sex workers
epidemiology (general)
hiv
hiv testing
men who have sex with men
surveillance
transgender women
Journal
Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
09
01
2019
revised:
15
04
2019
accepted:
20
05
2019
pubmed:
12
6
2019
medline:
1
7
2020
entrez:
12
6
2019
Statut:
ppublish
Résumé
To characterise the Joint United Nations Programme on HIV/AIDS 90-90-90 cascade among female sex workers (FSW) and men who have sex with men (MSM)/transgender women (TGW) in Port Moresby, Papua New Guinea (PNG). We conducted respondent-driven sampling surveys among FSW and MSM/TGW in Port Moresby, PNG from June to October 2016. All participants spoke English or Tok Pisin and were aged >12 years. FSW had to be born female and sell/exchange sex with a male in the past 6 months. MSM/TGW had to be born male and have oral/anal sex with another male-born person in the past 6 months. Participants were interviewed and offered rapid HIV diagnostic and viral load testing. HIV viral suppression (VS) was defined as <1000 copies/mL. We recruited 674 FSW and 400 MSM/TGW; HIV prevalence was 15.2% (95% CI 11.7 to 18.8) and 8.5% (95% CI 5.0 to 11.9), respectively. Among FSW living with HIV, 39.0% (95% CI 26.6 to 51.4) self-reported having been diagnosed; of them 79.6% (95% CI 62.7 to 96.5) self-reported being on antiretroviral therapy (ART), and 54.1% (95% CI 31.8 to 76.4) achieved VS. Among MSM/TGW living with HIV, 24.4% (95% CI 4.7 to 44.1) self-reported having been diagnosed; of them 43.9% (95% CI 33.6 to 54.8) self-reported being on ART, and 86.1% (95% CI 71.1 to 93.9) achieved VS. ART use among those aware of their HIV status is encouraging. However, the generally low awareness of infection status among FSW and MSM/TGW with HIV and the low VS among FSW on ART indicate an urgent need for innovative strategies to increase testing uptake and ART adherence among these populations. Monitoring drug resistance may be warranted.
Identifiants
pubmed: 31182653
pii: sextrans-2019-053961
doi: 10.1136/sextrans-2019-053961
pmc: PMC8678575
mid: NIHMS1761883
doi:
Substances chimiques
8,14-seco-3,5(10),9,11-estratetraene-3-methoxy-17 beta- hydroxy-14-one
0
Anti-Retroviral Agents
0
Estrenes
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
143-150Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : CDC HHS
ID : NU2GGH002093
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES014004
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH001531
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Sociol Methodol. 2011 Aug 1;41(1):355-366
pubmed: 22228916
PLoS One. 2014 Jan 28;9(1):e86719
pubmed: 24489776
PLoS One. 2017 Feb 1;12(2):e0170265
pubmed: 28146591
Int J Epidemiol. 2010 Dec;39(6):1541-55
pubmed: 20630991
Int J STD AIDS. 2016 Jan;27(1):5-12
pubmed: 25907348
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25119
pubmed: 30033654
J Sex Transm Dis. 2013;2013:953123
pubmed: 26316968
AIDS Behav. 2015 Dec;19(12):2194-203
pubmed: 26016470
N Engl J Med. 2000 Mar 30;342(13):921-9
pubmed: 10738050
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Cult Health Sex. 2013;15(4):450-65
pubmed: 23414116
Science. 2014 Jul 11;345(6193):158-61
pubmed: 25013060
Sex Transm Infect. 2004 Dec;80 Suppl 2:ii43-8
pubmed: 15572639
AIDS Behav. 2015 Feb;19(2):227-34
pubmed: 25086670
AIDS. 2016 Nov 13;30(17):2685-2695
pubmed: 27782965
Curr Opin HIV AIDS. 2010 Jul;5(4):305-10
pubmed: 20543605
AIDS Behav. 2016 Aug;20(8):1754-76
pubmed: 26992395
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660